Colliers is pleased to present the opportunity to acquire the fee-simple interest in 2380 Conejo Spectrum, a 97,193-square-foot, two-story Class A building on a six-acre site in Thousand Oaks’ Conejo Spectrum innovation cluster. Delivered 100% vacant, the Property represents a rare opportunity for an owner-user to acquire a recently renovated, turnkey headquarters facility at a basis well below replacement cost. Originally built in 2001 and comprehensively renovated in 2019, the building features 16’2” slab-to-slab ceiling heights, 100-pound floor live load capacity, large rectangular floor plates, M-1 zoning, and a 4/1,000 SF parking ratio—physical attributes that support a wide range of uses including office, R&D, life science, and flex. The Property is strategically positioned within one of Greater Los Angeles’ most established life science and corporate nodes, anchored by Amgen’s 2.9-million-square-foot global headquarters and its recently announced $600+ million Center for Science and Innovation expansion. Surrounding occupiers include Takeda, Sage Publishing, Atara Bio, Sensata Technologies, Charles River Labs, and FUJIFILM Diosynth Biotechnologies, creating one of the deepest concentrations of life science and R&D talent in Southern California. For an owner-user, the acquisition delivers compelling economics relative to leasing, while unlocking meaningful tax efficiency through bonus depreciation, long-term occupancy cost certainty, and full control over the asset. With no new office construction in the pipeline and continued removal of inventory through owner-user acquisitions and conversions, 2380 Conejo Spectrum is ideally suited for a corporate user seeking a long-term headquarters location.